003120 — Ilsung IS Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapValue Trap

Annual income statement for Ilsung IS Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	40,601	42,090	61,248	78,053	69,018
Cost of Revenue
Gross Profit	13,182	16,135	27,935	36,086	27,049
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	42,549	43,887	59,910	86,046	72,264
Operating Profit	-1,948	-1,797	1,338	-7,993	-3,246
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	4,417	-1,523	142,296	-21,345	11,163
Provision for Income Taxes
Net Income After Taxes	3,220	-1,368	108,669	-20,941	13,094
Net Income Before Extraordinary Items
Net Income	3,220	-1,368	108,669	-20,941	13,094
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	3,220	-1,368	108,669	-20,941	13,094
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	418	-179	14,532	-2,995	1,322
Dividends per Share